Stock price 2/9/10: $.30……..……….…….………..…….Common shares 9/30/09: 14.4mm
52 week Range: $0.35 to $1.01….….…………………Equity market capitalization: $4.3mm
Research, Report & Profiling Services
by IPOdesktop.com
Stock symbol: CREG.OB………………….….…..……….……….……… Ave volume (3 mos) 5mm
Stock price 10/8/09: $1.88…………..………..……..…………….Common shares 6/30/09: 38.8mm
52 week Range: $.22 to $1.92..….…..…………..……………Equity market capitalization: $73mm
Recent News …..Stock Price & Chart …..SEC Filings
BUSINESS
. Provides environmentally friendly waste-to-energy technologies to recycle industrial byproducts for steel mills, cement factories and coke plants in
. Byproducts include heat, steam, pressure, and exhaust to generate large amounts of lower-cost electricity and reduce the need for outside electrical sources.
Research, Report & Profiling Services
by IPOdesktop.com
Stock symbol: CHCG.OB…….…..……….…………..………….……… Ave volume (3mos) 240,400
Stock price 10/9/09: $.59……………..………………..…………….Common shares 6/30/09: 54mm
52 week Range: $.37 to $1.84….…..…………..……………Equity market capitalization: $31.8mm
Recent News …..Stock Price & Chart … ..SEC Filings
BUSINESS
. A leading wholesale distributor and retailer of 3C merchandise: computers, communication products and consumer electronics in
. Goal is to become the number one retailer of 3C products in
. Partners with large department stores and supermarkets, such as Wal-Mart, Carrefour, Best Buy, Trust-Mart, and Hualian.
Research, Report & Profiling Services
by IPOdesktop.com
Telestone Technologies Corp. (NASDAQ:TSTC)
Stock symbol: TSTC……………..……….….…..…..………….……… Ave volume (3 mos) 121,000
Stock price 10/14/09: $8.90…………..……..….…………….…………….Common shares: 10.4mm
52 week Range: $.63 to $8.95….…..…………..……………Equity market capitalization: $92.6mm
Research, Report & Profiling Services
by IPOdesktop.com
Sinovac Biotech (SVA)
Stock symbol: SVA………..……….….…..………..…..………….………Ave volume (3 mos) 5mm
Stock price 10/8/09: $7.08………….……..………..………….Common shares 6/30/09: 42.42mm
52 week Range: $.75 to $12.50….…..……………..………Equity market capitalization: $300mm
Recent News …..Stock Price & Chart …..SEC Filings
Supply vaccines to eliminate human diseases.
BUSINESS
· Research, development, commercialization, and sales of human vaccines for infectious illnesses such as Hepatitis A and Hepatitis B, influenza and “SARS”.
· Sinovac is the first and currently the only company in the world to have been granted permission to begin clinical trials for a vaccine to prevent SARS.
· Sinovac is one of the leading emerging biotechnology companies in